Ken Griffin Standard Biotools Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.42 - $2.35 $9,372 - $15,510	-6,600 Reduced 31.88%	14,100 $27,000
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.92 $33,495 - $59,276	20,300 Added 5075.0%	20,700 $36,000
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $187 - $278	100 Added 33.33%	400 $1,000
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $318 - $546	200 Added 200.0%	300 $0
Q3 2023 Nov 14, 2023	BUY	$1.9 - $3.05 $190 - $305	100 New	100 $0
Q1 2023 May 15, 2023	BUY	$1.3 - $2.24 $27,300 - $47,040	21,000 Added 437.5%	25,800 $50,000
Q4 2022 Feb 14, 2023	BUY	$0.93 - $1.52 $4,464 - $7,296	4,800 New	4,800 $5,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $148M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.